Lundbeck nears end of Brazilian sham litigation probe
Credit: iStock/Eugene_Axe
The chief investigator for Brazil’s antitrust authority has recommended dropping an investigation into Lundbeck, due to insufficient evidence the drugmaker conducted sham litigation in an abuse of dominance on the national pharmaceuticals market.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now